Related Experiment Videos
Therapeutic response to asthma medications: genotype predictors
Alison M Wallace1, Andrew J Sandford
1University of British Columbia, James Hogg iCapture Centre, St Paul's Hospital, Vancouver, British Columbia, Canada.
Treatments in Respiratory Medicine
|June 29, 2004
Summary
Genetic variations impact asthma drug effectiveness and side effects. Personalized pharmacogenetics approaches are needed to tailor treatments for better asthma management and identify new therapeutic targets.
Area of Science:
- Pharmacogenetics
- Pulmonology
- Medical Genetics
Background:
- Asthma represents a significant global health and economic challenge.
- Individual responses to asthma medications vary considerably.
- Genetic factors are known to influence drug efficacy and toxicity.
Observation:
- Pharmacogenetic studies aim to understand how genetic variations affect asthma treatment outcomes.
- Current research focuses on improving responses to beta(2)-adrenoceptor agonists and leukotriene modifiers.
- Genetic polymorphisms are implicated in inter-individual differences in medication effectiveness and adverse events.
Findings:
- Single nucleotide polymorphism and haplotype analyses have yielded inconclusive results regarding genotype-based asthma therapy optimization.
- Predictive genotype markers for optimizing current asthma treatments are not yet well-defined.
- Tailoring therapeutic regimens based on individual genetic profiles remains a goal.
Implications:
- Understanding asthma pharmacogenetics is crucial for personalized medicine.
- Further research is needed to identify reliable genetic predictors for asthma treatment.
- Defining new therapeutic targets through genetic studies holds promise for future asthma management.